Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Primate cell – per se
Reexamination Certificate
1998-12-08
2003-09-02
Spector, Lorraine (Department: 1646)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Primate cell, per se
C435S326000, C435S366000, C514S002600, C514S012200, C530S350000, C530S351000, C530S300000
Reexamination Certificate
active
06613565
ABSTRACT:
FIELD OF THE INVENTION
The present invention is directed to the use of Delta-like protein (dlk) to inhibit the rate of differentiation of stem cells.
BACKGROUND OF THE INVENTION
The differentiated cells of some biological systems mature in stages from a common progenitor cell, usually called a stem cell. Such cells include, for example, hematopoietic, neural, epithelial, endothelial, and mesodermal cells.
Stem cells are able to differentiate into mature cells within one of these systems. Differentiation may occur through uncommitted or committed progenitor cell intermediates.
The differentiation of a stem cell may result in one mature cell. Alternatively, a stem cell may differentiate into multiple mature lineages within a biological system, in which case the stem cell is said to be pluripotent. In some cases, the differentiation of a stem cell may result in all the mature lineages of an entire biological system, in which case the stem cell is said to be totipotent. Stem cells are also be able to self-renew. The self-renewal must be delicately balanced by differentiation in order to maintain a healthy level of stem cells.
For example, hematopoietic stem cells constitute approximately 0.01% of the cells in adult bone marrow. These stem cells, which can be recognized by the presence of the CD34 antigen, are found in micro-environments associated with stromal cells.
Hematopoietic stem cells are induced by various cytokines, such as c-kit and flk-2/flt-3 ligand, to differentiate into increasingly lineage-committed progenitors. These progenitors differentiate further into the various mature white blood cells, red blood cells, and platelets of the hematopoietic system.
Self-renewal of the stem cells requires their maintenance in an undifferentiated state. There are various applications for methods that increase the time during which stem cell populations remain undifferentiated in vivo and ex vivo. Such applications include, for example, gene therapy, and concentrating stem cell populations.
Another application for maintaining stem cells in an undifferentiated state is cell and tissue transplantation between animals. An example of this application, in the case of hematopoietic cells, is bone marrow transplantation.
Attempts to maintain and expand stem cells, especially hematopoietic stem cells, using various cytokines and cytokine mixtures have been unsuccessful. An object of the present invention is to provide methods for the maintenance of stem cells in an undifferentiated state. A more specific object is to provide methods for the maintenance of hematopoietic stem cells in an undifferentiated state. Another object is to provide a method for enriching a population of stem cells in a mixture of stem cells and non-stem cells.
SUMMARY OF THE INVENTION
These, and other, objects as will be apparent to those having ordinary skill in the art have been met by providing a method for inhibiting the differentiation of stem cells, such as hematopoietic stem cells; and a method for enriching a population of stem cells in a mixture of stem cells and non-stem cells. The methods comprise contacting the stem cells, or the mixture of stem cells and non-stem cells, with a sufficient amount of human delta-like protein (dlk).
REFERENCES:
patent: 5580738 (1996-12-01), Laborda
patent: 5644031 (1997-07-01), Laborda
patent: WO 94/13701 (1994-06-01), None
Bauer et al., Modulated expression of the epidermal growth factor-like homeotic protein dlk influences stromal-cell-pre-B-cell interactions, stromal cell adipogenesis, and pre-B-cell interleukin-7 requirements, Mole. Cell. Biol., 18(9): 5247-5255, Sep. 1998.*
Moore et al., Hematopoietic acitivity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs, Proc. Natl. Acad. Sci. USA, 94: 4011-4016, Apr. 1997.*
Chitnis et al., “Primary Neurogenesis in Xenopus Embryos Regulated by a Homologue of the Drosophila Neurogenic Gene Delta”, Nature, 375, 761-766 (1995).
Dexter et al., “The Structure of the Hemopoietic System,” Annu. Rev. Cell Biol., 3, 423-441 (1987).
Henrique et al., “Expression of a Delta Homologue in Prospective Neurons in the Chick”, Nature, 375, 787-790 (1995).
Laborda et al., “dlk, a Putative Mammalian Homeotic Gene Differentially Expressed in Small Cell Lung Carcinoma and Neuroendocrine Tumor Cell Line”, The Journal of Biological Chemistry, 268, 3817-3820 (1993).
Ellisen et al., “TAN-1, The Human Homolog of the Drosophila Notch Gene, Is Broken by Chromosomal Translocations in T Lymphoblastic Neoplasms,” Cell, 66, 649-661 (1991).
Fortini et al., “Notch: Neurogenesis Is Only Part of the Picture”, Cell, 75, 1245-1247 (1993).
Lee et al., “dlk, pG2 and Pref-1 mRNAs Encode Similar Proteins Belonging to the EGF-Like Superfamily. Identification of Polymorphic Variants of This RNA”, Biochimica et Biophysica Acta, 1261, 223-232 (1995).
Milner et al., “A Human Homologue of the Drosophila Developmental Gene, Notch, Is Expressed in CD34+Hematopoietic Precursors”, Blood, 83, 2057-2062 (1994).
Smas et al., “Pref-1, A Protein Containing EGF-Like Repeats, Inhibits Adipocyte Differentiation”, Cell, 73, 725-734 (1993).
Takemoto, “Mouse mRNA For Stromal Cell Derived Protein-1, and Translated Products”, GenBank, Submitted (Jul. 22, 1993). Accession No. D16847, published Jan. 15, 1994.
Wharton et al., “Nucleotide Sequence From the Neurogenic Locus Notch Implies a Gene Product That Shares Homology With Proteins Containing EGF-Like Repeats”, Cell, 43, 567-581 (1985).
Zipori et al., “Adherent Cells From Mouse Bone Marrow Inhibit the Formation of Colony Simulating Factor (CSF) Induced Myeloid Colonies”, Exp. Hematol. 8, 816-817 (1980).
Zipori et al., “Myelopoiesis in the Presence of Stromal Cells From Mouse Bone Marrow: I. Monosaccharides Regulate Colony Formation”, Exp. Hematol. 9, 656-663 (1981).
Lemischka Ihor R.
Moore Kateri A.
Pytowski Bronislaw
Witte Larry
Gallagher Thomas C.
Hoffman & Baron LLP
ImClone Systems Incorporated
Kaufman Claire M.
Spector Lorraine
LandOfFree
Use of delta-like protein to inhibit the differentiation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of delta-like protein to inhibit the differentiation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of delta-like protein to inhibit the differentiation of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3052364